BASI Insider Trading Activity and SEC Form 4 Filings
BASI insider trading summary
No open-market insider purchases or sales of Bioanalytical Systems Inc (BASI) have been reported on SEC Form 4 in the past 12 months.
Latest BASI insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Mar 5, 2021 | Beth Taylor | VP- Finance & CFO | Buy | $89K (5,000 @ $17.70) |
| Mar 1, 2021 | John Gregory Beattie | Chief Operating Officer | Buy | $32K (1,712 @ $18.60) |
| Feb 24, 2021 | Robert Leasure Jr. | President and CEO | Buy | $72K (5,000 @ $14.42) |
| Feb 23, 2021 | John Gregory Beattie | Chief Operating Officer | Buy | $116K (8,288 @ $14.00) |
| Aug 19, 2020 | R Matthew Neff | Director | Buy | $24K (5,000 @ $4.75) |
| Aug 19, 2020 | John E Sagartz | Chief Strategy Officer | Buy | $18K (3,733 @ $4.75) |
| Jun 15, 2020 | Robert Leasure Jr. | President and CEO | Buy | $15K (2,884 @ $5.20) |
| May 21, 2020 | Beth Taylor | VP- Finance & CFO | Buy | $15K (3,300 @ $4.52) |
| May 21, 2020 | William D Pitchford | Chief HR Officer | Buy | $45K (10,000 @ $4.47) |
| May 20, 2020 | Beth Taylor | VP- Finance & CFO | Buy | $22K (4,933 @ $4.42) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.